LAVA Therapeutics NV (LVTX) — Net Asset Quality Index
LAVA Therapeutics NV (LVTX) has a Net Asset Quality Index of 24.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $51.91 Million minus total liabilities of $39.23 Million yields net assets of $12.68 Million. A higher index indicates a stronger, lower-leverage balance sheet. See LVTX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
LAVA Therapeutics NV Net Asset Quality Index Over Time (2019–2024)
This chart shows how LAVA Therapeutics NV's Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the index stands at 24.4%, representing net assets of $12.68 Million against total assets of $51.91 Million USD. Explore LVTX cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for LAVA Therapeutics NV (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for LAVA Therapeutics NV from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is LAVA Therapeutics NV worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 34.3% | $27.75 Million | $80.83 Million | $53.09 Million | ▼ -16.0 pp |
| 2023 | 50.3% | $51.18 Million | $101.71 Million | $50.53 Million | ▼ -9.7 pp |
| 2022 | 60.0% | $86.04 Million | $143.43 Million | $57.38 Million | ▼ -25.0 pp |
| 2021 | 85.0% | $118.37 Million | $139.25 Million | $20.88 Million | ▲ +47.8 pp |
| 2020 | 37.2% | $7.62 Million | $20.49 Million | $12.87 Million | ▼ -29.2 pp |
| 2019 | 66.4% | $5.84 Million | $8.80 Million | $2.95 Million | — |